Fee Fight Brewing Over Bioscience Co. Suit Deal In Chancery
A stockholder has objected to another investor's bid for $850,000 in attorney fees in connection with a proposed settlement to end a derivative suit in Delaware Chancery Court over an allegedly...To view the full article, register now.
Already a subscriber? Click here to view full article